Introduction
Intracellular
Many of the characterized resistance (R) genes used to confer disease resistance in crop breeding programs encode NLR proteins (Kourelis and van der Hoorn, 2018). However, NLR-mediated resistance can be overcome through silencing or deletion of effectors in pathogen genomes, the gain of new effectors or effector functions, or mutation to evade NLR activation (Raffaele et al., 2010; Yoshida et al., 2016). Engineering NLRs to detect currently unrecognized effector proteins would provide new opportunities to control plant pathogens. Early attempts to engineer NLRs focused on random mutagenesis followed by gain-of-function screening, with some success in both expanding recognition profiles to new effector variants and increasing the sensitivity of the receptor (Giannakopoulou et al., 2015; Segretin et al., 2014; Farnham and Baulcombe, 2006; Harris et al., 2013). More recently, modification of the effector target PBS1, which is guarded by the NLR protein RPS5 led to successful engineering of novel recognition by this system (Kim et al., 2016; Pottinger et al., 2020; Pottinger and Innes, 2020; Helm et al., 2019). RPS5 is activated by cleavage of the
Integrated domains can facilitate the recognition of structure- and sequence-diverse effectors which target similar host proteins. This is exemplified by the TIR-NLR pair RRS1 and RPS4, which mediate recognition of the structurally distinct effectors PopP2 from
The paired rice CC-NLR proteins Pik-1 and Pik-2 cooperatively activate plant defense in response to the blast pathogen effector AVR-Pik (Ashikawa et al., 2008; Kanzaki et al., 2012; Zdrzałek et al., 2020). The sensor NLR Pik-1 contains an integrated HMA domain between the CC and NB-ARC domains (Maqbool et al., 2015, Figure 1—figure supplement 1a). Direct binding of AVR-Pik to the HMA domain is required to activate Pik-mediated immunity (Maqbool et al., 2015; De la Concepcion et al., 2018; De la Concepcion et al., 2021). Multiple Pik alleles have been described in different rice cultivars, with most amino acid polymorphisms located within the integrated HMA domain of Pik-1. Five Pik alleles (Pikp, Pikm, Pikh, Piks, and Pik*) have been functionally characterized for their response to blast isolates carrying different AVR-Pik variants (Maqbool et al., 2015; Kanzaki et al., 2012; De la Concepcion et al., 2018; De la Concepcion et al., 2021, Figure 1—figure supplement 1c). To date, six AVR-Pik variants (A-F) have been described, which differ in five amino acid positions at the HMA-binding interface (Kanzaki et al., 2012; Yoshida et al., 2009; Longya et al., 2019, Figure 1—figure supplement 1b). These polymorphisms influence the binding of the effector to the integrated HMA domain of Pik-1 (Maqbool et al., 2015; De la Concepcion et al., 2018; Longya et al., 2019). Interestingly, the Asp67 and Lys78 polymorphisms of AVR-PikC and AVR-PikF, respectively, disrupt interactions between the effector and all tested integrated Pik-HMA domains (Maidment et al., 2021; De la Concepcion et al., 2021; Longya et al., 2019). To date, none of the characterized Pik alleles can confer disease resistance to blast isolates carrying AVR-PikC or AVR-PikF (Maqbool et al., 2015; Kanzaki et al., 2012; De la Concepcion et al., 2018; De la Concepcion et al., 2021).
The molecular basis of interaction between AVR-Pik effectors and the integrated HMA domains of Pikp-1, Pikm-1, and Pikh-1 has been well explored (Maqbool et al., 2015; De la Concepcion et al., 2018; De la Concepcion et al., 2021). Pikp-1 is only able to recognize the AVR-PikD variant, however, the introduction of two amino acid changes (Asn261Lys and Lys262Glu) extends recognition to AVR-PikE and AVR-PikA, phenocopying the recognition profile of Pikm-1 and Pikh-1 (De la Concepcion et al., 2019).
The NLR pair RGA5 and RGA4 detect the blast pathogen effectors AVR-Pia and AVR1-CO39, with activation requiring binding of the effector to an integrated HMA domain at the C-terminus of RGA5 (Okuyama et al., 2011; Cesari et al., 2013; Ortiz et al., 2017). Crystal structures of the RGA5-HMA/AVR1-CO39 and Pik-HMA/AVR-Pik complexes were used to engineer the RGA5-HMA domain to bind AVR-PikD in addition to its cognate effectors AVR-Pia and AVR1-CO39 and deliver cell death in
The AVR-Pik effector targets members of the rice heavy metal-associated isoprenylated plant protein (HIPP) and heavy metal-associated plant protein (HPP) families through direct interaction with their HMA domain, supporting the hypothesis that NLR integrated domains are likely derived from host proteins (Oikawa et al., 2020; Maidment et al., 2021). In a previous study, we showed that all AVR-Pik effector variants bind to the HMA domain of OsHIPP19 with high affinity and elucidated the structural basis of this interaction by determining the crystal structure of a OsHIPP19-HMA/AVR-PikF complex (Maidment et al., 2021). This shows that effector variants that are not bound by Pik-HMA domains, and escape immune recognition, retain a tight binding for HMA domains of their putative host targets.
Here, we leverage our understanding of the interaction between OsHIPP19 and AVR-Pik to engineer the integrated HMA domain of Pik-1 to expand recognition to the stealthy AVR-PikC and AVR-PikF variants, enabling new-to-nature disease resistance profiles in an NLR. We use two parallel strategies to engineer recognition. First, we demonstrate that exchanging the HMA domain of Pikp-1 for that of OsHIPP19 (including additional amino acid substitutions to prevent autoactivity), gives a chimeric Pik-1 which binds AVR-Pik effectors and triggers AVR-PikC- and AVR-PikF-dependent cell death in
Results
A Pikp-1OsHIPP19 chimera extends binding and response to previously unrecognized AVR-Pik variants
Previously, we reported that all AVR-Pik variants, including AVR-PikC and AVR-PikF, bind to the HMA domain of OsHIPP19 with high affinity (Maidment et al., 2021). The HMA domains of Pikp-1 and OsHIPP19 share 51% amino acid identity and are structurally similar; the RMSD (as calculated in Coot using secondary structure matching) between Pikp-HMA (PDB 6G10) and OsHIPP19-HMA (PDB 7B1I) is 0.97 Å across 71 amino acids. We hypothesized that exchanging the HMA domain of Pikp-1 for the HMA domain of OsHIPP19 would result in an NLR capable of binding and responding to AVR-PikC and AVR-PikF.
For this exchange, amino acids 188–263 (inclusive) of Pikp-1 were replaced with amino acids 2–77 of OsHIPP19 to give the chimeric NLR protein Pikp-1OsHIPP19 (Figure 1—figure supplement 2a). To test whether Pikp-1OsHIPP19 could associate with AVR-Pik effector variants in planta, we performed co-immunoprecipitation experiments in
We then transiently co-expressed epitope-tagged Pik-1, Pikp-2, and AVR-Pik in
Figure 1.
The Pikp-1OsHIPP19-mbl7 chimera expands binding and response to previously unrecognized AVR-Pik effector variants.
(A) Representative leaf image showing the Pikp-1OsHIPP19 chimera is autoactive in
Figure 1—figure supplement 1.
Domain structure and resistance profiles for the proteins in this study.
(A) Cartoon representation of the OsHIPP19, Pik-1, and Pik-2 domains, with numbers giving the amino acid domain boundaries. CC = Coiled coil, HMA = Heavy-metal-associated, NB-ARC = Nucleotide-binding found in APAF-1, R proteins and CED4, LRR = Leucine rich repeat. (B) Cartoon representation of AVR-Pik effector variants. Amino acid polymorphisms between variants are shown as single-letter codes with the number giving the position. SP = signal peptide. (C) Summary of the recognition profiles of known Pik nucleotide-binding and leucine-rich repeat (NLR) alleles against AVR-Pik variants (tick = resistant, cross = susceptible).
Figure 1—figure supplement 2.
Schematic representation of the Pikp-1OsHIPP19 (A) and Pikp-1OsHIPP19-mbl7 (B) chimeras.
The amino acid sequence below indicates junctions between the sequence derived from Pikp-1 (blue highlight) and from OsHIPP19 (gray highlight).
Figure 1—figure supplement 3.
Western blots following co-immunoprecipitation show that the Pikp-1OsHIPP19 chimera binds to all AVR-Pik effector variants except, surprisingly, AVR-PikF in
Plant cell lysates were probed for the expression of Pikp-1/Pikp-1OsHIPP19 and AVR-Pik effector variants using anti-FLAG and anti-Myc antiserum, respectively. Total protein extracts were visualized by Ponceau Staining.
Figure 1—figure supplement 4.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of experiments presented in Figure 1a, c and e (panels A, B, and C; respectively).
Each replicate consisted of 10 (A) or 20 (B, C) repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates in panels A, B, and C were combined and represented as the dot plots in Figure 1b, d and f, respectively.
Figure 1—figure supplement 5.
The Pikp-1OsHIPP19 chimera requires both the P-loop and MHD motifs in Pikp-2 for autoactivity, and the P-loop in Pikp-1 for full cell death.
(A) Example leaf showing the P-loop mutant (K217R, middle, left) and MHD mutant (D559V, bottom, left) in Pikp-2 abolishes autoactive cell death, whereas the P-loop mutant in Pikp-1OsHIPP19 (K196R, top, left) reduces the cell death response. (B) Pikp-mediated response scoring represented as dot plots to summarize 54 repeats of the experiment shown in (A) across three independent experiments (Materials and methods, Figure 1—figure supplement 6). Fluorescence intensity is scored as stated in Figure 1. (C) Western blots confirming the accumulation of proteins in
Figure 1—figure supplement 6.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 1—figure supplement 5a.
Each replicate consisted of 18 repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plot in Figure 1—figure supplement 5b.
Figure 1—figure supplement 7.
Western blots confirm the accumulation of proteins in
Plant cell lysates were probed for the expression of Pikp-1/Pikp-1OsHIPP19/Pikp-1OsHIPP19-mbl7, Pikp-2, and AVR-Pik effector variants using anti-FLAG, anti-HA, and anti-Myc antiserum, respectively. Total protein extracts were visualized by Ponceau Staining.
Figure 1—figure supplement 8.
Location of the β1-α1 loop (brown) in Pikp-HMA (blue) is distant from the effector (green) binding surface in the crystal structure of complexes between these proteins.
Structure shown is based on PDB entry 6G10. Protein structures are presented as ribbons.
Figure 1—figure supplement 9.
Statistical analysis by estimation methods of the cell death assays presented in Figure 1, for Pikp-1OsHIPP19-mbl7/Pikp-2 with (A) AVR-PikD, AVR-PikC and empty vector, and (B) AVR-PikD, AVR-PikF, and empty vector.
The panel on the left represents the ranked data (dots) for the three replicates of each effector/control, and their corresponding mean (dotted line). The size of the dots is proportional to the number of observations with that specific value. The panel on the right shows the distribution of 1000 bootstrap sample rank means for Pikp-1OsHIPP19-mbl7/Pikp-2/AVR-PikD and Pikp-1OsHIPP19-mbl7/Pikp-2/AVR-PikC (A) or Pikp-1OsHIPP19-mbl7/Pikp-2 (B). The red areas represent the 2.5th and 97.5th percentiles of the distribution. The response of Pikp-1OsHIPP19-mbl7/Pikp-2 to AVR-PikD, AVR-PikC, and AVR-PikF is considered significantly different to the response of Pikp-1OsHIPP19-mbl7/Pikp-2 to the empty vector as the rank means of the latter (dotted line, left panel) falls beyond the red regions of the Pikp-1OsHIPP19-mbl7/Pikp-2/AVR-PikD, Pikp-1OsHIPP19-mbl7/Pikp-2/AVR-PikC, and Pikp-1OsHIPP19-mbl7/Pikp-2/AVR- mean distributions.
Figure 1—figure supplement 10.
The Pikp-1OsHIPP19-mbl7 chimera responds to AVR-PikE and AVR-PikA.
(A) Representative leaf image showing the Pikp-1OsHIPP19-mbl7 chimera is not autoactive and triggers Pikp-2-dependent cell death in response to AVR-PikE and AVR-PikA. By contrast, Pikp-1 only triggers cell death in response to AVR-PikD, and not AVR-PikE nor AVR-PikA. NLR-mediated responses appear as autofluorescence imaged under UV light. (B) Pikp-mediated response scoring represented as dot plots to summarize 29 repeats of the experiment shown in (A) across three independent experiments (Materials and Methods, Figure 1—figure supplement 11). Fluorescence intensity is scored as stated in Figure 1.
Figure 1—figure supplement 11.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 1—figure supplement 10a.
Replicates 1 and 3 consisted of 10 repeats for each sample, and replicate 2 consisted of 9 repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plot in Figure 1—figure supplement 10b.
A previous study showed that autoactivity following HMA domain exchange could be abolished by reverting the degenerate metal-binding motif of the HMA domain (‘MxCxxC’) to the corresponding amino acids in Pikp-1 (Białas et al., 2021). Based on this observation, we exchanged seven amino acids (encompassing the entire MxCxxC motif) in the β1-α1 loop of the Pikp-1OsHIPP19 chimera for the corresponding amino acids in Pikp-1 (Figure 1—figure supplement 2b, Figure 1—figure supplement 8). The resulting chimera, Pikp-1OsHIPP19-mbl7 hereafter (mbl7 refers to seven amino acids in the ‘
Structure-guided mutagenesis of Pikp-1 extends response to previously unrecognized AVR-Pik variants
Alongside the HMA-domain exchange strategy, we also used a structure-guided approach to target point mutations in Pikp-HMA that could extend the effector recognition profile of Pikp without triggering autoimmunity.
The interaction surfaces between integrated Pik-HMA domains and AVR-Pik effectors are well-characterized, with crystal structures revealing three predominant interfaces (termed 1–3) between the proteins (Maqbool et al., 2015; De la Concepcion et al., 2018; De la Concepcion et al., 2021; De la Concepcion et al., 2019). These interfaces are also observed in the structure of the HMA domain of OsHIPP19 in complex with AVR-PikF (PDB accession code 7B1I Maidment et al., 2021). The Asp67 and Lys78 polymorphisms that distinguish AVR-PikC and AVR-PikF from AVR-PikE and AVR-PikA, respectively, are located at interface 2. In the crystal structure of Pikh-HMA/AVR-PikC, the side chain of AVR-PikCAsp67 extends towards a loop in the HMA domain containing Pikh-HMAAsp224. This loop is shifted away from the effector, likely due to steric clash and/or repulsion by the two Asp sidechains, and intermolecular hydrogen bonds between Pikh-HMAAsp224 and AVR-PikCArg64 are disrupted. We hypothesized that compensatory mutations at interface 2 could mitigate against the disruption caused by AVR-PikCAsp67. Therefore, we introduced Asp224Ala and Asp224Lys mutations in the Pikp-1NK-KE background (De la Concepcion et al., 2019) and tested these constructs in cell death assays in
Pikh-1 and Pikp-1NK-KE differ from Pikp-1 by one and two amino acids, respectively, at interface 3. These amino acid differences are sufficient to extend binding and cell death response to AVR-PikE and AVR-PikA, even though the residues that distinguish these variants from AVR-PikD are located at interface 2. We, therefore, predicted that we could engineer a modified Pik-1 that interacts with AVR-PikC/AVR-PikF by mutating other interfaces in the HMA domain to compensate for disruption at the site of the polymorphic residue. The crystal structure of the OsHIPP19-HMA/AVR-PikF complex revealed additional hydrogen bond interactions at interface 3 relative to integrated HMAs in the complex with AVR-Pik variants (Maidment et al., 2021). The side chain of OsHIPP19Glu72 was particularly striking. The corresponding residue in all described Pik-1 HMA domains is serine, and while the hydroxyl group of the serine side chain only forms an intramolecular hydrogen bond within the HMA domain, the bulkier OsHIPP19Glu72 side chain extends across the interface and forms a direct hydrogen bond with the effector (Figure 2a). We, therefore, introduced a Ser258Glu mutation in the Pikp-1NK-KE background to give the triple mutant Pikp-1SNK-EKE and tested the ability of this protein to respond to AVR-Pik variants in
Figure 2.
Structure-guided mutagenesis of Pikp-1 expands response to previously unrecognized AVR-Pik effector variants.
(A) Comparison of the crystal structures of AVR-Pik effector variants in complex with Pik-HMA domains (PDB entries 6G10, 6FU9, and 7A8X) and AVR-PikF in complex OsHIPP19 (PDB entry 7B1I) suggests the addition of an S258E mutation to the NK-KE mutations described previously (De la Concepcion et al., 2019) could introduce new contacts across the protein:protein interface. Protein structures are represented as ribbons with relevant side chains displayed as cylinders. Dashed lines indicate hydrogen bonds. Relevant water molecules are represented as red spheres. (B) The PikpSNK-EKE mutant gains response to AVR-PikC (right, middle) where no response is observed for PikpNK-KE (left, middle). Further, the PikpSNK-EKE mutant is not autoactive (right, bottom) and retains response to AVR-PikD (right, top). All infiltration spots contain Pikp-2. (C) Pikp-mediated response scoring represented as dot plots to summarize 60 repeats of the experiment shown in (B) across three independent experiments (Materials and methods, Figure 2—figure supplement 3a). (D) and (E) as described for (B) and (C) but with AVR-PikF and 57 repeats across three independent experiments (Materials and methods, Figure 2—figure supplement 3b).
Figure 2—figure supplement 1.
The mutations D224A and D224K mutations in the PikpNK-KE background do not extend response to AVR-PikC.
(A) Neither the Pikp-1DNK-AKE nor the Pikp-1DNK-KKE mutant gains response to AVR-PikC (left, middle and left, top), and response to AVR-PikD is reduced in both mutants (right, middle and right, top). All infiltration spots contain Pikp-2. (B) Pikp-mediated response scoring represented as dot plots to summarize 30 repeats of the experiment shown in (A) across three independent experiments (Materials and methods, Figure 2—figure supplement 2). Fluorescence intensity is scored as stated in Figure 1. (C) Western blots confirming the accumulation of proteins in
Figure 2—figure supplement 2.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 2—figure supplement 1a.
Each replicate consisted of 10 repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plot in Figure 2—figure supplement 1b.
Figure 2—figure supplement 3.
Pikp-mediated response scoring represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 2b (A) and 2d (B).
Each replicate consisted of 20 (A) and 19 (B) repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plots in Figure 2c and e, respectively.
Figure 2—figure supplement 4.
Statistical analysis by estimation methods of the cell death assays presented in Figure 2, for Pikp-1NK-KE/Pikp-2 and Pikp-1SNK-EKE/Pikp-2 with (A) AVR-PikC and (B) AVR-PikF.
The panel on the left represents the ranked data (dots) for the three replicates of each receptor/effector, and their corresponding mean (dotted line). The size of the dots is proportional to the number of observations with that specific value. The panel on the right shows the distribution of 1000 bootstrap sample rank means for Pikp-1SNK-EKE/Pikp-2/AVR-PikC (A) or Pikp-1SNK-EKE/Pikp-2/AVR-PikF (B). The red areas represent the 2.5th and 97.5th percentiles of the distribution. The response of Pikp-1SNK-EKE/Pikp-2 to AVR- AVR-PikC/AVR-PikF is considered significantly different to the response of Pikp-1NK-KE/Pikp-2 to AVR-PikC/AVR-PikF as the rank means of the latter (dotted line, left panel) falls beyond the red regions of the Pikp-1NK-KE/Pikp-2/AVR-PikC and Pikp-1NK-KE/Pikp-2/AVR-PikF mean distributions.
Figure 2—figure supplement 5.
Western blots confirm the accumulation of proteins in
(A) Accumulation of proteins for the experiments with AVR-PikC. (B) Accumulation of proteins for the experiments with AVR-PikF. Plant cell lysates were probed for the expression of Pikp-1NK-KE/Pikp-1SNK-EKE, Pikp-2, and AVR-Pik effector variants using anti-FLAG, anti-HA, and anti-Myc antiserum, respectively. Total protein extracts were visualized by Ponceau Staining.
Figure 2—figure supplement 6.
Pikp-1SNK-EKE chimera responds to AVR-PikE and AVR-PikA.
(A) Representative leaf image showing Pikp-1SNK-EKE is not autoactive and triggers Pikp-2-dependent cell death in response to AVR-PikE and AVR-PikA. As previously published (De la Concepcion et al., 2019), Pikp-1NK-KE also triggers cell death in response to AVR-PikE and AVR-PikA in a Pikp-2-dependent manner. Nucleotide-binding and leucine-rich repeat (NLR)-mediated responses appear as autofluorescence imaged under UV light. (B) Pikp-mediated response scoring represented as dot plots to summarize 29 repeats of the experiment shown in (A) across three independent experiments (Materials and methods, Figure 2—figure supplement 7). Fluorescence intensity is scored as stated in Figure 1.
Figure 2—figure supplement 7.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 2—figure supplement 6a.
Replicates 2 and 3 consisted of 10 repeats for each sample, and replicate 1 consisted of 9 repeats for each sample. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plot in Figure 2—figure supplement 6b.
Figure 2—figure supplement 8.
The Pikp S258E mutation alone does not extend response to AVR-PikC or AVR-PikF.
(A) The Pikp-1S258E mutant does not gain response to AVR-PikC (left, middle) or AVR-PikF (right, middle). All infiltration spots contain Pikp-2. (B) Pikp-mediated response scoring represented as dot plots to summarize 54 repeats of the experiment shown in (A) across three independent experiments (Materials and methods, Figure 2—figure supplement 9). Fluorescence intensity is scored as stated in Figure 1. (C) Western blots confirming the accumulation of proteins in
Figure 2—figure supplement 9.
Pikp-mediated response scoring is represented as dot plots, subdivided by replicate, for repeats of the experiment presented in Figure 2—figure supplement 8a.
The three replicates consisted of 18, 20, and 16 repeats for each sample, respectively. Fluorescence intensity is scored as described in Figure 1. Scores from the three replicates were combined and represented as the dot plot in Figure 2—figure supplement 8b, respectively.
We tested whether the Ser258Glu mutation alone was sufficient to extend the cell death response to AVR-PikC or AVR-PikF using the cell death assay. When Pikp-1S258E was co-infiltrated with Pikp-2 and either AVR-PikC or AVR-PikF no cell death was observed (Figure 2—figure supplement 8, Figure 2—figure supplement 9), demonstrating that the triple mutation is necessary for response to these effectors.
The Ser258Glu mutation extends the binding of Pikp-HMANK-KE to AVR-PikC and AVR-PikF in vitro
The extent of the Pik/AVR-Pik-dependent cell death response in
Figure 3.
The SNK-EKE triple mutation extends Pikp-1 binding to AVR-PikC and AVR-PikF in vitro and in planta by facilitating new contacts across the protein:protein interface.
Boxplots showing the %Rmax observed for the interactions between AVR-PikC (A) or AVR-PikF (B), both at 40 nM injection concentration, and each of Pikp-HMA, Pikp-HMANK-KE, and Pikp-HMASNK-EKE. %Rmax is the percentage of the theoretical maximum response, assuming a 2:1 binding model (as previously observed for Pikp-HMA proteins). The centre line of the box represents the median and the box limits are the upper and lower quartiles. The whiskers extend to the smallest value within Q1 − 1.5 X the interquartile range (IQR) and the largest value within Q3 +1.5 X IQR. Individual data points are represented as black shapes. The experiment was repeated three times, with each experiment consisting of three technical replicates. Data for 4 nM and 100 nM effector injection concentrations are shown in Figure 3—figure supplement 1. (C) Western blots following co-immunoprecipitation show that the Pikp-1SNK-EKE chimera binds to tested AVR-Pik effector variants in
Figure 3—figure supplement 1.
Boxplots showing the %Rmax observed for the interactions between AVR-PikC (A) or AVR-PikF (B), both at 4 nM and 100 nM injection concentrations, and each of Pikp-HMA, Pikp-HMANK-KE, and Pikp-HMASNK-EKE.
%Rmax is the percentage of the theoretical maximum response, assuming a 2:1 binding model (as previously observed for Pikp-HMA proteins, see Materials and methods).The center line of the box represents the median and the box limits are the upper and lower quartiles. The whiskers extend to the smallest value within Q1 − 1.5 Å ~the interquartile range (IQR) and the largest value within Q3 + 1.5 Å ~IQR. Individual data points are represented as black shapes. The experiment was repeated three times, with each experiment consisting of three technical replicates.
Figure 3—figure supplement 2.
Schematic representation of the crystal structure of the complex formed between Pikp-HMANK-KE and AVR-PikC (PDB entry 7A8W).
The overall structure is similar to other Pik-HMA/AVR-Pik complexes. Amino acid residues forming key contacts at the interface are labeled, including Asp67 which distinguishes AVR-PikC from AVR-PikE.
Figure 3—figure supplement 3.
Schematic representation of the crystal structure of the complex formed between Pikp-HMASNK-EKE and AVR-PikC (PDB entry 7QPX).
The overall architecture of the complexes is similar to other Pik-HMA/AVR-Pik structures. Amino acid residues forming key contacts at the interface are labeled, including Asp67 which distinguishes AVR-PikC from AVR-PikE.
Figure 3—figure supplement 4.
Schematic representation of the crystal structure of the complex formed between Pikp-HMASNK-EKE and AVR-PikF (PDB entry 7QZD).
The overall architecture of the complexes is similar to other Pik-HMA/AVR-Pik structures. Amino acid residues forming key contacts at the interface are labeled, including Lys78 which distinguishes AVR-PikF from AVR-PikA.
The Ser258Glu mutation extends the binding of Pikp-HMANK-KE to AVR-PikC and AVR-PikF in planta
Next, we determined whether the Ser258Glu mutation also extends binding to AVR-PikC and AVR-PikF in the full-length NLR in planta using co-immunoprecipitation. Full-length Pikp-1, Pikp-1NK-KE, and Pikp-1SNK-EKE were each co-expressed with either AVR-PikD, AVR-PikC, or AVR-PikF in
Crystal structures of the Pikp-HMASNK-EKE/AVR-PikC and Pikp-HMASNK-EKE/AVR-PikF complexes reveal new contacts across the binding interface
To confirm that the side chain of Glu258 in Pikp-1SNK-EKE forms a new hydrogen bond across the interface (as observed for Glu72 in the OsHIPP19/AVR-PikF complex), we determined the crystal structures of the Pikp-HMASNK-EKE/AVR-PikC and Pikp-HMASNK-EKE/AVR-PikF complexes. For comparison, we also determined the crystal structure of Pikp-HMANK-KE/AVR-PikC. These were produced by co-expression in
The global structures of the complexes are essentially identical to each other and to the previously determined Pik-HMA/AVR-Pik crystal structures (Figure 3—figure supplement 2, Figure 3—figure supplement 3, Figure 3—figure supplement 4, Supplementary file 1). The RMSDs, as calculated in COOT with secondary structure matching, between Pikp-HMANK-KE/AVR-PikC and Pikp-HMASNK-EKE/AVR-PikC or Pikp-HMASNK-EKE/AVR-PikF are 0.38 Å using 154 residues and 0.60 Å using 155 residues, respectively. Interface analysis performed with qtPISA (Krissinel and Henrick, 2009) identified 15 hydrogen bonds and nine salt bridges between Pikp-HMASNK-EKE and AVR-PikC, and 16 hydrogen bonds and 11 salt bridges between Pikp-HMASNK-EKE and AVR-PikF, compared to the 12 hydrogen bonds and eight salt bridges mediating the interaction between Pikp-HMANK- KE and AVR-PikC (Supplementary file 2). Inspection of the structures revealed that the side chain of Glu258 does indeed extend across the interface, forming direct hydrogen bonds with the backbone of the effectors (Figure 3d). This single mutation also supports additional hydrogen bonds at the interface between AVR-PikC (or AVR-PikF) and residues comprising β4 of the HMA domain (Figure 3d). These differences at interface 3 likely explain the increased binding affinity of Pikp-HMASNK-EKE for AVR-PikC/AVR-PikF relative to Pikp-HMANK-KE.
Rice plants expressing PikpOsHIPP19-mbl7 or Pikp-1SNK-EKE are resistant to
To determine whether the engineered Pik NLRs Pikp-1OsHIPP19-mbl7 and Pikp-1SNK-EKE could mediate resistance to
Figure 4.
Transgenic rice plants carrying the
(A) Example leaves from pathogenicity assays of wild-type
Figure 4—figure supplement 1.
RT-PCR to confirm transgene expression of
Figure 4—figure supplement 2.
Pathogenicity assays in the T1 progenies derived from a
Images of leaves from different T1 lines were taken 7 days after inoculation. Gel images show PCR confirmation of transgenes. The plants show susceptibility to all
Figure 4—figure supplement 3.
Pathogenicity assays in the T1 progenies derived from six independent
Images of leaves from different T1 lines were taken 7 days after inoculation. Gel images show PCR confirmation of transgenes. The plants show resistance to all
Figure 4—figure supplement 4.
Pathogenicity assays in the T1 progenies derived from five independent
Images of leaves from different T1 lines were taken 7 days after inoculation. Gel images show PCR confirmation of transgenes. The plants show resistance to all
Discussion
Plant diseases cause significant crop losses and constrain global food production. To develop disease-resistant crops, breeding programs exploit resistance genes present in wild germplasm that can be introgressed into elite cultivars. While recent advances have accelerated efforts to identify and clone resistance genes (Mascher et al., 2014; Arora et al., 2019; Jupe et al., 2013; Gardiner et al., 2020), conventional breeding approaches are constrained by the recognition profiles of resistance genes present in wild germplasm. Rational engineering of NLR immune receptors has the potential to yield novel disease resistance traits and expand the repertoire of resistance genes available to combat plant pathogens. It also offers the potential to restore disease resistance that has been overcome by pathogens and accelerate responses to dynamic changes in pathogen-effector populations. Here, we took two approaches to engineer the integrated HMA domain of the NLR protein Pik-1 to deliver new-to-nature effector recognition profiles.
The stealthy effector variants AVR-PikC and AVR-PikF do not interact with the integrated HMA domains of any Pik alleles characterized to date with sufficiently high affinity to activate defense. By contrast, as a putative virulence target of AVR-Pik, OsHIPP19 is bound by all effector variants, including AVR-PikC and AVR-PikF with high affinity (Maidment et al., 2021; Oikawa et al., 2020). Using this knowledge, and the relationship between OsHIPP19 and integrated Pik-HMA domains, we engineered two Pik-1 variants, Pikp-1OsHIPP19-mbl7, and Pikp-1SNK-EKE. These engineered Pik-1 proteins bound AVR-PikC and AVR-PikF, activated cell death in
Despite the structural similarity of the OsHIPP19 and Pikp-1 HMA domains, the Pikp-1OsHIPP19 chimera triggered effector-independent cell death in
Based on the OsHIPP19/AVR-PikF complex (Maidment et al., 2021), we incorporated a Ser258Glu point mutation in the Pikp-1NK-KE background, generating a Pikp-HMA triple mutant, Pikp-1SNK-EKE. By determining the crystal structures of the Pikp-HMASNK-EKE/AVR-PikC and Pikp-HMASNK-EKE/AVR-PikF complexes, we confirmed the formation of new contacts across the HMA/effector interface that likely account for the expanded recognition profile to AVR-PikC and AVR-PikF. In addition to a new hydrogen bond between the side chain of Pikp- 1SNK-EKE_Glu258 and the backbone of AVR-PikC, we observed two additional intermolecular hydrogen bonds formed between other amino acids at the interface. This extended hydrogen bonding is facilitated by a shift in β4 of the HMA domain towards the effector. Together with previous studies in the Pik-1/Pik-2 and RGA5/RGA4 systems (De la Concepcion et al., 2019; Cesari et al., 2022; Liu et al., 2021), our new results show the utility of structure-guided approaches to engineering NLR integrated domains to extend binding to different effectors. While recent advances in protein structure modeling will support future engineering efforts, challenges remain in the accurate prediction of side-chain positions, and the effect of individual mutations, which will necessitate experimental determination of protein complexes to optimize intermolecular interactions.
The Pikp-1SNK-EKE variant differs from the wild-type Pikh-1 allele in just two amino acid positions. Generating Pikp-1SNK-EKE from Pikh-1 requires a maximum of four nucleotide substitutions, which can be achieved using precise base editing and prime editing technologies (Molla et al., 2021; Hua et al., 2022). In many countries, edited crop varieties which do not contain DNA from another species are not subject to restrictions beyond those required for conventionally bred crop varieties. Therefore, this work raises the exciting prospect of editing wild-type alleles of NLRs that have greater potential for deployment in the field than those incorporating entirely new protein domains or substantial sequence changes.
Given the limited number of
Advances in our understanding of the molecular and structural basis of NLR activation have progressed efforts for the rational engineering of NLR proteins with altered recognition profiles. Previous studies have successfully engineered integrated domains to extend recognition capacities, though so far this has either resulted in the regeneration of resistance already conferred by other NLRs (De la Concepcion et al., 2019; Cesari et al., 2022; Liu et al., 2021) or provided recognition of a protein not present in the native pathogen (Kourelis et al., 2023). In this study, we use an effector target to guide the engineering of an integrated domain to deliver two engineered Pik-1 variants with new-to-nature effector recognition profiles. The chimeric NLR Pikp-1OsHIPP19-mbl7 highlights the potential to incorporate diverse HMA domains without rendering the chimera autoactive. The triple mutant Pikp-1SNK-EKE illustrates the benefit of structural/biochemical characterization of effector-target interactions to inform rational engineering. Crucially, both engineered NLR proteins deliver novel resistance in transgenic rice, and have potential for deployment in the field against
Materials and methods
Gene cloning for protein expression in
For protein expression in planta, full-length Pikp-1 NLRs containing the OsHIPP19 HMA domain (and Pikp-1OsHIPP43-mbl7), the Pikp-1SNK-EKE mutation (made by introducing the S258E mutation in the HMA domain by PCR), and other HMA domain mutations were assembled using Golden Gate cloning into the plasmid pICH47742 with a C-terminal 6xHis/3xFLAG tag. Expression was driven by the
Gene cloning, expression, and purification of proteins for in vitro binding studies
For SPR, Pikp-HMANK-KE and Pikp-HMASNK-EKE (residues Gly186 – Asp264) variants were cloned into pOPIN-M (generating a 3 C protease cleavable N-terminal 6xHis:MBP-tag). AVR-PikD, AVR-PikC, and AVR-PikF (residues Glu22 – Phe93) were cloned into pOPIN-E (generating a C-terminal non-cleavable 6xHis-tag, but also including a 3 C protease cleavable N-terminal SUMO-tag, as detailed previously Maqbool et al., 2015). The Pikp-HMANK-KE and Pikp-HMASNK-EKE proteins were expressed and purified using the same pipeline as described below for obtaining protein complexes for crystallization, whereas the effectors were retained on the second pass through the 5 ml Ni2+-NTA column (which served to remove the SUMO tag following 3 C cleavage) requiring specific elution with elution buffer (50 mM Tris-HCl pH 8.0, 50 mM glycine, 0.5 M NaCl, 500 mM imidazole, 5% (v/v) glycerol), followed by gel filtration using a Superdex 75 26/600 column equilibrated in running buffer (20 mM HEPES pH 7.5 and 150 mM NaCl). Proteins were concentrated and stored at –80°C for further studies.
Cloning, expression, and purification of proteins for crystallization
For crystallization of the Pikp-HMANK/KE/AVR-PikC, Pikp-HMASNK/EKE/AVR-PikC and Pikp-HMASNK/EKE/AVR-PikF complexes, Pikp-HMA (residues Gly186 – Asp264) variants were cloned into pOPIN-M and AVR-PikC or AVR-PikF into pOPIN-A using InFusion cloning. Chemically competent
Protein crystallization, data collection, structure solution, refinement, and validation
Crystallization trials were set up in 96-well plates using an Oryx Nano robot (Douglas Instruments) with 0.3 μl of protein combined with 0.3 μl reservoir solution. Crystals of each complex were obtained in multiple conditions using the commercially available Morpheus screen (Molecular Dimensions). Crystals used for X-ray data collection were obtained from condition F8 (Pikp-HMANK/KE/AVR-PikC complex), D7 (Pikp-HMASNK/EKE/AVR-PikC), and H4 (Pikp-HMASNK/EKE/AVR-PikF). The crystals were snap-frozen in liquid nitrogen and shipped to Diamond Light Source for X-ray data collection. Diffraction data were collected at the Diamond Light Source, i04, and i03 beamlines (see Supplementary file 1), under proposals mx13467 and mx18565. The data were scaled and merged by Aimless in the CCP4i2 software package (Potterton et al., 2018). Each of the structures was solved by molecular replacement using PHASER (McCoy et al., 2007). The search models used were the Pikp-HMA/AVR-PikD complex (PDB entry: 5A6W) for Pikp-HMANK/KE/AVR-PikC, the Pikp-HMANK/KE/AVR-PikC complex (PDB entry: 7A8W) for Pikp-HMASNK/EKE/AVR-PikC, and the Pikp-HMA/AVR-PikD complex (PDB entry: 5A6W) for Pikp-HMASNK/EKE/AVR-PikF. Iterative cycles of the manual model building using COOT (Emsley and Cowtan, 2004) and refinement with REFMAC (Murshudov et al., 2011) were used to derive the final structures, which were validated using the tools in COOT and MolProbity (Williams et al., 2018). The final protein structures, and the data used to derive them, have been deposited at the Protein Data Bank with IDs 7A8W (Pikp-HMANK/KE/AVR-PikC), 7QPX (Pikp-HMASNK/EKE/AVR-PikC), and 7QZD (Pikp-HMASNK/EKE/AVR-PikF).
In vitro protein-protein interaction studies: SPR
SPR was performed using a Biacore T200 (Cytiva) at 25 °C and at a flow rate of 30 µl/min. The running buffer was 20 mM HEPES pH 7.5, 860 mM NaCl, and 0.1%(v/v) Tween20. Flow cell (FC) 2 of an NTA chip (GE Healthcare) was activated with 30 µl 0.5 mM NiCl2. 30 µl of the 6xHis-tagged effector (the ligand) was immobilized on FC2 to give a response of ~250 RU. The HMA domain (the analyte) was then flowed over both FC1 and FC2 for 360 s, followed by a dissociation time of 180 s. Three separate concentrations of each HMA were tested, 4 nM, 40 nM, and 100 nM. The NTA chip was regenerated after each cycle with 30 µl 0.35 M EDTA pH 8.0. The background response from FC1 (non-specific binding of the HMA domain to the chip) was subtracted from the response from FC2. To obtain %Rmax, the binding response (Robs) was measured immediately prior to the end of injection and expressed as a percentage of the theoretical maximum response (Rmax) assuming a 2:1 HMA:effector binding model for Pikp-HMA, PikpNK-KE-HMA, and PikpSNK-EKE-HMA calculated as follows:
Data analysis and visualization was carried out in R v4.1.2 (R Core Development Team, 2018) using the packages dplyr (v1.0.9 [Wickham, 2022]) and ggplot2 (v3.3.6 [Wickham, 2016]).
Confirmation of protein production in cell death assays by western blot analysis
Western blot analysis was used to confirm the presence of proteins in
Samples were subjected to SDS-PAGE/western blot analysis to detect epitope-tagged proteins. Pikp-1, Pikp-2, and AVR-Pik effectors were detected by probing membranes with anti-FLAG-HRP (Generon, 1:10,000 dilution), anti-HA-HRP (Thermo Fisher Scientific, 1:3000 dilution) and anti-Myc-HRP (Santa Cruz, 1:5000 dilution) antibodies, respectively, and LumiBlue ECL Extreme (Expedeon). Membranes were also stained with Ponceau S to observe protein loading.
In planta protein-protein interaction studies: co-immunoprecipitation
For co-immunoprecipitation assays, three leaves were harvested at 3 dpi and flash-frozen in liquid nitrogen. Leaf tissue was ground to a fine powder in liquid nitrogen using a pre-chilled pestle and mortar and resuspended in ice-cold plant protein extraction buffer (2 ml/mg of powder). Plant cell debris was pelleted by centrifugation at 4200 ×
Fungal strains and transformation
To generate
Rice transformation and confirmation of transgene expression
To generate constructs for rice transformation, Golden Gate Level 1 constructs encoding a hygromycin resistance cassette (35 S promoter/nos terminator), untagged
PCR confirmation of the presence of
To confirm transgene expression, total RNA was extracted from leaves using an SV Total RNA Isolation System (Promega, WI, USA) and used for RT-PCR. cDNA was synthesized from 500 ng total RNA using a Prime Script RT Reagent Kit (Takara Bio, Otsu, Japan). RT-PCR was performed using three primer sets,
Disease resistance/virulence assays in rice
Rice leaf blade punch inoculation was performed using the
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2023, Maidment et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
A subset of plant intracellular NLR immune receptors detect effector proteins, secreted by phytopathogens to promote infection, through unconventional integrated domains which resemble the effector’s host targets. Direct binding of effectors to these integrated domains activates plant defenses. The rice NLR receptor Pik-1 binds the
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer